Polysomnography Study of GSK1838262 Extended Release Tablets Versus Placebo in RLS and Associated Sleep Disturbance

NCT00748098 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

136

Enrollment

INDUSTRY

Sponsor class

Conditions

Restless Legs Syndrome
Restless Legs Syndrome (RLS)

Interventions

DRUG: GSK1838262 Extended Release Tablets
DRUG: Placebo

Sponsor

XenoPort, Inc.